Evidence map›Paper›PMID 38742107›Full record

ArticleFrontiers in immunology2024

SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.

Patricia P Ogger, Minerva Garcia Martín, Soyeon Jang, Jie Zhou, Jonathan Brown, Ksenia Sukhova, Wilhelm Furnon, Arvind H Patel, Vanessa Cowton, Massimo Palmarini and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Patricia P OggerSection of Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Minerva Garcia MartínSection of Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Soyeon JangSection of Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Jie ZhouDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Jonathan BrownDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Ksenia SukhovaDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Wilhelm FurnonMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Arvind H PatelMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Vanessa CowtonMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Massimo PalmariniMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Wendy S BarclayDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Cecilia JohanssonSection of Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: SARS-CoV-2, the cause of the COVID pandemic, is an RNA virus with a high propensity to mutate. Successive virus variants, including variants of concern (VOC), have emerged with increased transmission or immune escape. The original pandemic virus and early variants replicated poorly, if at all, in mice at least partly due to a mismatch between the receptor binding domain on the viral spike protein and the murine angiotensin converting enzyme 2 (ACE2). Omicron VOC emerged in late 2021 harboring > 50 new mutations, 35 of them in the spike protein. This variant resulted in a very large wave of infections, even in the face of prior immunity, albeit being inherently less severe than earlier variants. Reflecting the lower severity reported in humans, Omicron displayed attenuated infection in hamsters and also in the K18- Methods: Here we infected Results: While replication of SARS-CoV-2 Omicron was lower in the lungs of Discussion: Since this chimeric virus efficiently infected C57BL/6 wildtype mice, and replicated in their lungs, our findings illustrate a pathway for genetic mapping of virushost interactions during SARS-CoV-2 infection.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19Mice, Inbred C57BLSARS-CoV-2Spike Glycoprotein, CoronavirusVirus ReplicationAnimalsDisease Models, AnimalGene Knock-In TechniquesHumansMiceMice, TransgenicAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusknockout micerespiratory infectionSARS-CoV-2spike proteinvariant

Identifiers

PMID38742107
PMCPMC11089223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.